- Company Overview for GRAEGIS PHARMACEUTICALS LIMITED (13680871)
- Filing history for GRAEGIS PHARMACEUTICALS LIMITED (13680871)
- People for GRAEGIS PHARMACEUTICALS LIMITED (13680871)
- More for GRAEGIS PHARMACEUTICALS LIMITED (13680871)
Persons with significant control: 0 active persons with significant control / 1 active statement
Statement Active
- The company knows or has reasonable cause to believe that there is no registrable person or registrable relevant legal entity in relation to the company
- Notified on
- 14 October 2023
Clevexel Pharma Ceased
- Correspondence address
- 19 Avenue D'Italie, Paris, France, 75013
- Notified on
- 1 August 2023
- Ceased on
- 14 October 2023
- Governing law
- Legal form
- Simplified Joint Stock Company (Société Par Actions Simplifiée)
- Place registered
- Paris Commercial Registry
- Registration number
- 790 115 026
- Incorporated in
- France
- Nature of control
- Ownership of voting rights - More than 25% but not more than 50%
Clevexel Pharma Ceased
- Correspondence address
- 19 Avenue D'Italie, Paris, France, 75013
- Notified on
- 20 December 2021
- Ceased on
- 1 August 2023
- Governing law
- Legal form
- Simplified Joint Stock Company (Société Par Actions Simplifiée)
- Place registered
- Paris Commercial Registry
- Registration number
- 790 115 026
- Incorporated in
- France
- Nature of control
Medicxi Iii Lp Ceased
- Correspondence address
- 44 Esplanade, St Helier, Jersey, Jersey, JE4 9WG
- Notified on
- 1 December 2021
- Ceased on
- 14 October 2023
- Governing law
- Legal form
- Limited Partnership
- Place registered
- Jersey
- Registration number
- 2938
- Incorporated in
- Jersey
- Nature of control
Mr Richard Michael Lee Ceased
- Correspondence address
- C/O The Cambridge Partnership, The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, United Kingdom, CB22 3FH
- Notified on
- 14 October 2021
- Ceased on
- 1 December 2021
- Date of birth
- December 1981
- Nationality
- British
- Country of residence
- England
- Nature of control
- Ownership of voting rights - 75% or more
- Right to appoint or remove directors